Revisión
Células madre de la piel: en la frontera entre el laboratorio y la clínica. Parte I: células madre epidérmicas
Skin Stem Cells: At the Frontier Between the Laboratory and Clinical Practice. Part 1: Epidermal Stem Cells
a Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Bruselas, Bélgica
b Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España
c Servicio de Dermatología, Hospital San Jorge, Huesca, España
d Instituto Aragonés de Ciencias de la Salud, Zaragoza, España
e Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Université Libre de Bruxelles (ULB), Bruselas, Bélgica
Leído
45162
Vecesse ha leído el artículo
9709
Total PDF
35453
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 304 | 19 | 323 |
| 2025 10 | 749 | 53 | 802 |
| 2025 9 | 538 | 29 | 567 |
| 2025 8 | 333 | 54 | 387 |
| 2025 7 | 547 | 46 | 593 |
| 2025 6 | 628 | 39 | 667 |
| 2025 5 | 982 | 66 | 1048 |
| 2025 4 | 1082 | 59 | 1141 |
| 2025 3 | 995 | 47 | 1042 |
| 2025 2 | 1001 | 60 | 1061 |
| 2025 1 | 671 | 56 | 727 |
| 2024 12 | 733 | 56 | 789 |
| 2024 11 | 819 | 104 | 923 |
| 2024 10 | 764 | 48 | 812 |
| 2024 9 | 723 | 73 | 796 |
| 2024 8 | 569 | 87 | 656 |
| 2024 7 | 531 | 70 | 601 |
| 2024 6 | 473 | 63 | 536 |
| 2024 5 | 631 | 76 | 707 |
| 2024 4 | 571 | 157 | 728 |
| 2024 3 | 605 | 148 | 753 |
| 2024 2 | 753 | 110 | 863 |
| 2024 1 | 936 | 109 | 1045 |
| 2023 12 | 623 | 117 | 740 |
| 2023 11 | 851 | 201 | 1052 |
| 2023 10 | 726 | 133 | 859 |
| 2023 9 | 633 | 139 | 772 |
| 2023 8 | 444 | 67 | 511 |
| 2023 7 | 543 | 96 | 639 |
| 2023 6 | 660 | 136 | 796 |
| 2023 5 | 694 | 126 | 820 |
| 2023 4 | 589 | 98 | 687 |
| 2023 3 | 502 | 119 | 621 |
| 2023 2 | 397 | 102 | 499 |
| 2022 1 | 390 | 111 | 501 |
| 2022 12 | 342 | 81 | 423 |
| 2022 11 | 556 | 137 | 693 |
| 2022 10 | 548 | 115 | 663 |
| 2022 9 | 543 | 117 | 660 |
| 2022 8 | 383 | 85 | 468 |
| 2022 7 | 303 | 118 | 421 |
| 2022 6 | 380 | 116 | 496 |
| 2022 5 | 431 | 186 | 617 |
| 2022 4 | 288 | 73 | 361 |
| 2022 3 | 373 | 137 | 510 |
| 2022 2 | 290 | 90 | 380 |
| 2021 1 | 372 | 132 | 504 |
| 2021 12 | 247 | 95 | 342 |
| 2021 11 | 449 | 122 | 571 |
| 2021 10 | 504 | 157 | 661 |
| 2021 9 | 253 | 100 | 353 |
| 2021 8 | 307 | 97 | 404 |
| 2021 7 | 314 | 107 | 421 |
| 2021 6 | 417 | 142 | 559 |
| 2021 5 | 396 | 128 | 524 |
| 2021 4 | 1202 | 345 | 1547 |
| 2021 3 | 485 | 118 | 603 |
| 2021 2 | 374 | 131 | 505 |
| 2020 1 | 284 | 103 | 387 |
| 2020 12 | 244 | 97 | 341 |
| 2020 11 | 316 | 121 | 437 |
| 2020 10 | 313 | 140 | 453 |
| 2020 9 | 232 | 77 | 309 |
| 2020 8 | 136 | 76 | 212 |
| 2020 7 | 159 | 105 | 264 |
| 2020 6 | 180 | 120 | 300 |
| 2020 5 | 193 | 136 | 329 |
| 2020 4 | 199 | 116 | 315 |
| 2020 3 | 128 | 114 | 242 |
| 2020 2 | 7 | 104 | 111 |
| 2020 1 | 6 | 87 | 93 |
| 2019 12 | 8 | 122 | 130 |
| 2019 11 | 4 | 137 | 141 |
| 2019 10 | 0 | 89 | 89 |
| 2019 9 | 5 | 88 | 93 |
| 2019 8 | 4 | 62 | 66 |
| 2019 7 | 4 | 81 | 85 |
| 2019 6 | 4 | 104 | 108 |
| 2019 5 | 8 | 152 | 160 |
| 2019 4 | 2 | 144 | 146 |
| 2019 3 | 2 | 80 | 82 |
| 2019 2 | 4 | 75 | 79 |
| 2019 1 | 2 | 59 | 61 |
| 2018 12 | 1 | 82 | 83 |
| 2018 11 | 2 | 61 | 63 |
| 2018 10 | 6 | 5 | 11 |
| 2018 9 | 3 | 41 | 44 |
| 2018 8 | 0 | 84 | 84 |
| 2018 7 | 0 | 47 | 47 |
| 2018 6 | 2 | 96 | 98 |
| 2018 5 | 0 | 73 | 73 |
| 2018 4 | 0 | 52 | 52 |
| 2018 3 | 0 | 41 | 41 |
| 2018 2 | 45 | 26 | 71 |
| 2018 1 | 20 | 65 | 85 |
| 2017 12 | 66 | 41 | 107 |
| 2017 11 | 40 | 60 | 100 |
| 2017 10 | 1 | 29 | 30 |
| 2017 9 | 4 | 15 | 19 |
| 2017 8 | 4 | 27 | 31 |
| 2017 7 | 5 | 9 | 14 |
| 2017 6 | 14 | 38 | 52 |
| 2017 5 | 5 | 25 | 30 |
| 2017 4 | 10 | 34 | 44 |
| 2017 3 | 1 | 27 | 28 |
| 2017 2 | 3 | 24 | 27 |
| 2016 1 | 3 | 13 | 16 |
| 2016 12 | 4 | 14 | 18 |
| 2016 11 | 10 | 20 | 30 |
| 2016 10 | 1 | 10 | 11 |
| 2016 9 | 0 | 19 | 19 |
| 2016 8 | 1 | 3 | 4 |
| 2016 7 | 3 | 3 | 6 |
| 2016 6 | 7 | 1 | 8 |
| 2016 5 | 1 | 1 | 2 |
| 2015 11 | 0 | 31 | 31 |
Mostrar todo
